FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

96334000: Prednisolone acetate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
159452010 Prednisolone acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
840676015 Prednisolone acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
21181000188119 prednisolone acétate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
835471000172113 acétate de prednisolone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prednisolone acetate Is a Acetate false Inferred relationship Some
Prednisolone acetate Is a Product containing prednisolone (medicinal product) false Inferred relationship Some
Prednisolone acetate Is a Prednisolone (substance) false Inferred relationship Some
Prednisolone acetate Is a Synthetic glucocorticoid false Inferred relationship Some
Prednisolone acetate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Prednisolone (substance) true Inferred relationship Some
Prednisolone acetate Is a Immunosuppressant (substance) true Inferred relationship Some
Prednisolone acetate Is a Pregnane (substance) true Inferred relationship Some
Prednisolone acetate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that modifies the immune response or the functioning of the immune system. true Inferred relationship Some
Prednisolone acetate Is a Antineoplastic agent (substance) true Inferred relationship Some
Prednisolone acetate Is a Glucocorticoid (substance) true Inferred relationship Some
Prednisolone acetate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Prednisolone acetate [musculoskeletal use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 25mg/mL injection suspension 1mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 50mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 25mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 50mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 50mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 25mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 1.25 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 10 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 1% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Gentamicin sulfate + prednisolone acetate 0.3%/0.6%ww ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Gentamicin sulfate + prednisolone acetate 0.3%/1%vv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate + sulfacetamide sodium 0.2%wv/10%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate + sulfacetamide sodium 0.25%wv/10%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate + sulfacetamide sodium 5mg/100mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate + sulfacetamide sodium 5mg/100mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Gentamicin sulfate + prednisolone acetate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate + sulfacetamide sodium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate + sulfacetamide sodium 0.5%ww/10%ww ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Product containing precisely prednisolone 1 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Product containing precisely prednisolone 3 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone 3 mg/mL oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 50mg/mL injection suspension 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Prednisolone acetate 50mg/mL injection suspension 30mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Prednisolone acetate Inferred relationship Some
Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Prednisolone acetate Inferred relationship Some 1
Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Prednisolone acetate Inferred relationship Some 1
Product containing precisely prednisolone acetate 25 milligram/1 milliliter conventional release suspension for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Prednisolone acetate Inferred relationship Some 1
Product containing precisely prednisolone acetate 25 milligram/1 milliliter conventional release suspension for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Prednisolone acetate Inferred relationship Some 1
Prednisolone acetate 25 mg/mL suspension for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Prednisolone acetate Inferred relationship Some 1
Prednisolone acetate 25 mg/mL suspension for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Prednisolone acetate Inferred relationship Some 1
Prednisolone acetate 1.25 mg/mL eye suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Prednisolone acetate Inferred relationship Some 1
Prednisolone acetate 1.25 mg/mL eye suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Prednisolone acetate Inferred relationship Some 1
Prednisolone acetate 10 mg/mL eye suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Prednisolone acetate Inferred relationship Some 1
Prednisolone acetate 10 mg/mL eye suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Prednisolone acetate Inferred relationship Some 1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Prednisolone acetate Inferred relationship Some 1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Prednisolone acetate Inferred relationship Some 1
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Prednisolone acetate Inferred relationship Some 2
Prednisolone acetate 2 mg/g and sulfacetamide sodium 100 mg/g eye ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Prednisolone acetate Inferred relationship Some 2
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Prednisolone acetate Inferred relationship Some 2
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Prednisolone acetate Inferred relationship Some 2
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Prednisolone acetate Inferred relationship Some 1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Prednisolone acetate Inferred relationship Some 1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Prednisolone acetate Inferred relationship Some 1
Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Prednisolone acetate Inferred relationship Some 1
Product containing precisely prednisolone (as prednisolone acetate) 5 milligram/1 gram conventional release oromucosal paste (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Prednisolone acetate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start